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Caloric restriction (CR) has been shown to increase the life span and health span of a broad range of species.
However, CR effects on in vivo brain functions are far from explored. In this study, we used multimetric
neuroimaging methods to characterize the CR-induced changes of brain metabolic and vascular functions
in aging rats.We found that old rats (24months of age)with CRdiet had reduced glucose uptake and lactate
concentration, but increased ketone bodies level, comparedwith the age-matched and young (5months of
age) controls. The shiftedmetabolismwas associatedwith preserved vascular function: old CR rats also had
maintained cerebral blood ﬂow relative to the age-matched controls. When investigating the metabolites
in mitochondrial tricarboxylic acid cycle, we found that citrate and a-ketoglutarate were preserved in the
old CR rats.We suggest that CR is neuroprotective; ketone bodies, cerebral blood ﬂow, and a-ketoglutarate
may play important roles in preserving brain physiology in aging.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction Caloric restriction (CR) is the most studied antiaging manipu-Brain energy demands are among the highest of all organs. As a
result, the cerebral metabolic rates of glucose (CMRGlc) and cerebral
blood ﬂow (CBF) are quite high at baseline. Awidely accepted cause
of the functional losses that accompany aging is decreased brain
metabolic and vascular functions (Bentourkia et al., 2000;
Wallace, 2005). In support of this viewpoint, a host of neuro-
imaging studies show that CMRGlc and CBF decline with age
(Bentourkia et al., 2000; Lin and Rothman, 2014; Wallace, 2005)
and decline still more rapidly and profoundly in Alzheimer’s disease
(AD) (Cunnane et al., 2011; Hoyer, 1991; Nagata et al., 1997). The
metabolic and hemodynamic reductions precede brain structural
alteration (gray matter and white matter atrophy) and cognitive
impairment (Bookheimer et al., 2000; Cunnane et al., 2011;
Reiman et al., 2001). Therefore, preserving brain metabolism
(i.e., glucose oxidative capacity) and hemodynamics are critical for
optimizing health span (Stranahan and Mattson, 2012).er on Aging, University of
Tel.:þ1859 323 6671; fax:þ1
Inc. This is an open access article ulation and has been shown to increase the life span of a broad range
of species (Choi et al., 2011; Colman et al., 2009; Rahat et al., 2011).
In the nervous system, CR has been shown to reduce oxidative
stress, enhance neurotrophin levels, restore neuronal structure
(Stranahan et al., 2009), and enhance cognitive function
(Fontan-Lozano et al., 2008; Mattson, 2010; Valdez et al., 2010;
Witte et al., 2009). In a recent study, we found that Fischer 344
Brown-Norway F1 (F344BNF1) rats under chronic CR had preserved
mitochondrial function and neuronal activity (Lin et al., 2014).
Speciﬁcally, compared with young rats, old rats with CR diet had
similar ﬂuxes of neuronal tricarboxylic acid (TCA) cycle and gluta-
mate (Glu)-glutamine (Gln) neurotransmitter cycling (Lin et al.,
2014). As TCA cycle ﬂux is associated with metabolism (e.g.,
CMRGlc) and neuronal activity is associated with vascular integrity
(e.g., CBF) (Fox and Raichle, 1986; Lin et al., 2010), this indicates that
CR may also be able to impede the age-related decline of brain
metabolic and vascular functions.
In this study, our goal was to identify CR effects on cerebral
metabolism and blood ﬂow in the same animal model. Speciﬁcally,
we used in vivo neuroimaging to measure CMRGlc and CBF. We also
used mass spectroscopy to determine the brain metabolites and
identify the metabolic pathway associated with the changes undernder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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physiology in aging brain.2. Material and methods
2.1. Animal
Experiments were conducted usingmale F344BNF1 rats because
this particular strain has demonstrated extended longevity under
CR (Turturro et al., 1999). Young control (5 months, N ¼ 6), old
control, and old calorie-restricted rats (24 months, N ¼ 6 for each
group) were obtained from the National Institute on Aging Caloric
Restricted Colony. The sample size was determined with power
analysis to perform the comparison at a 0.05 level of signiﬁcance,
with a 90% chance of detecting a true difference of all the mea-
surements between the 3 groups.
At National Institute on Aging, all rats were fed ad libitum
(National Institutes of Health [NIH]-31 diet) until 14 weeks of age.
The CR regimen was initiated by incremental caloric reduction of
10% per week over 4 weeks, reaching full 40% CR by week 16. The
vitamin-fortiﬁed NIH-31 (NIH-31 fortiﬁed) diet fed to CR rats pro-
vided 60% of the calories and additional vitamins supplement
consumed by ad libitum rats. After arriving at our facilities, rats
were housed individually (1 rat per cage) in a speciﬁc pathogen-free
facility and were fed the same diet 1 hour before the onset of the
dark cycle. All experimental procedures were approved by the
Institutional Animal Care and Use Committee at the University of
Texas Health Science Center at San Antonio according to NIH
guidelines.2.2. Animal preparation for functional neuroimaging
Rats were anesthetized with 4.0% isoﬂurane for induction and
then maintained in a 1.2% isoﬂurane and air mixture using a face
mask. Heart rate (90e130 bpm.), respiration rate, and rectal tem-
perature (37  0.5 C) were continuously monitored. A water bath
with circulating water at 45e50 C was used to maintain the body
temperature. Heart rate and blood oxygen saturation level were
recorded using a MouseOx system (STARR Life Science, Oakmont,
PA, USA) and maintained within normal physiological ranges.2.3. Cerebral metabolic rate of glucose (CMRGlc) measurements
CMRGlc was measured using ﬂuorodeoxyglucose (18FDG)
positron emission tomography (PET) methods (Focus 220
microPET, Siemens, Nashville, TN, USA). A quantity of 0.5 mCi of
18FDG dissolved in 1 mL of physiologic saline solution was
injected through the tail vein. Forty minutes were allowed for
18FDG uptake before scanning. Animals were then moved to the
scanner bed and placed in the prone position. Emission data
were acquired for 20 minutes in a 3-dimensional (3D) list mode
with intrinsic resolution of 1.5 mm. For image reconstruction,
3D PET data was rebinned into multiple frames of 1-second
duration using a Fourier algorithm. After rebinning the data, a
3D image was reconstructed for each frame using a 2D-ﬁltered
back projection algorithm.
Decay and dead time corrections were applied to the recon-
struction process. Cerebral metabolic rate of glucose was deter-
mined using the mean standardized uptake value (SUV) equation:
SUV (A W)/Ainj, where A is the activity of the region of interest
(i.e., brain region in the study), W is the body weight of the rat, and
Ainj is the injection dose of the 18FDG, as described in a previous
study (Lin et al., 2012b).2.4. Cerebral blood ﬂow (CBF) measurements
We used magnetic resonance imaging (MRI) to measure CBF.
Quantitative CBF (with units of mL/g perminute) was obtainedwith
MRI-based continuous arterial spin labeling (CASL) techniques on a
horizontal 7 T/30 cm magnet (Bruker, Billerica, MA, USA), as
described previously (Lin et al., 2012b). A circular surface coil was
placed on top of the head and a circular labeling coil was placed at
the heart position for CASL. The 2 coils were positioned parallel
to each other and were actively decoupled. Paired images were
acquired in an interleaved fashion with ﬁeld of view ¼ 12.8  12.8
mm2, matrix ¼ 128  128, slice thickness ¼ 1 mm, 10 slices,
labeling duration ¼ 2100 ms, repetition time ¼ 3000 ms, and echo
time ¼ 20 ms. CASL image analysis employed codes written in
MATLAB (Natick, MA, USA) and STIMULATE software (University of
Minnesota, Minneapolis, MN, USA) to obtain CBF.2.5. Brain metabolites measurements
We used high-performance liquid chromatography-electrospray
ionization-mass spectrometry (HPLC-ESI-MS) to measure brain
metabolites. Rats were sacriﬁced at the end of the MRI study. Brain
tissues from the cortex and hippocampus were separated and
frozen with liquid N2. Those brain tissues were then homogenized
and extracted with icy cold 80% aqueous methanol and maintained
on ice for 1 hour. The cell extracts were centrifuged at 13,800g for
10 minutes and the supernatants were transferred to glass auto-
sampler vials for HPLC-ESI-MS analysis.
HPLC-ESI-MS analyses were conducted on a Thermo Fisher
Q Exactive mass spectrometer with on-line separation by a Thermo
Fisher/Dionex UltiMate 3000 HPLC. HPLC conditions were: column,
Luna NH2, 3 mm, 2  150 mm (Phenomenex; Torrance, CA, USA);
mobile phase A, 5% acetonitrile in water containing 20-mM
ammonium acetate, and 20-mM ammonium hydroxide, pH 9.45;
mobile phase B, acetonitrile; ﬂow rate, 300 mL/min; gradient, 85%
B to 1% B over 10 minutes and held at 1% B for 10 minutes. Pro-
genesis CoMet Software (Nonlinear Dynamics) was used to process
the raw data ﬁles. We quantiﬁed the concentration of metabolites
by measuring the area under the curve and detected the metabo-
lites that exhibited signiﬁcant differences in abundance. Metabolite
identiﬁcation was performed through METLIN database searching
using a 5-ppmmass tolerance, manual interpretation of the MS/MS
fragment patterns, and agreement with the HPLC retention time of
authentic standards.2.6. Blood ketone bodies measurements
When the rats were sacriﬁced, blood sample was collected in a
2-mLBDtubecoatedwithof LithiumHeparin (VacutainerK2EDTA) to
avoid blood coagulation. Twenty ﬁve microliter of blood sample was
used to measure blood ketone bodies level of each rat using an STAT-
Site Analyzer-Ketone Photometer and STAT-Site b-hydroxybutyrate
(BHB) test cards. (Standbio Laboratory, Boerne, TX, USA).2.7. Statistical analysis
Statistical analyses were performed using GraphPad Prism
(GraphPad, San Diego, CA, USA). Signiﬁcance of differences among
means of the 3 groups was evaluated using 1-way analysis of
variance followed by Tukey’s post hoc test. Evaluation of differences
between 2 groups was done using Student t test. Values of p < 0.05
were considered signiﬁcant.
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3.1. CR-reduced brain glucose metabolism
Fig. 1A shows a representative single slice of the CMRGlc
maps overlaid on the corresponding anatomical image. Color
bar shows the minimal and maximal CMRGlc in SUV in the
linear scale. The maps show that old control rats overall had
signiﬁcantly lower CMRGlc compared with the young controls;
the old CR had signiﬁcantly lower global CMRGlc relative to both
control groups. The quantitative CMRGlc values are shown in
Fig. 1B. We further did regional analyses on the entire cortex,
hippocampus, and hypothalamus. We chose cortex and hippo-
campus because they are related to cognitive functions and the
hypothalamus is related to glucose sensing. Similar to the
pattern in global CMRGlc, old control rats showed lower regional
CMRGlc than those in the young ones (though not signiﬁcant in
the cortex); old CR rats had signiﬁcantly lower CMRGlc
compared with the 2 control groups in cortex (Fig. 1C), hippo-
campus (Fig. 1D), and hypothalamus (Fig. 1E). The results sug-
gest that CMRGlc declines with age, and CR further reduces
glucose utilization in aging.3.2. CR preserved CBF
Fig. 2A shows a representative single slice of CBF maps overlaid
on the corresponding anatomical image. Color bar shows the
minimal and maximal CBF (in mL/g/min) in the linear scale. The
maps show that old control rats overall had signiﬁcantly lower CBF
than that of the young controls. However, old CR rats had indis-
tinguishable CBF compared with the young controls. Quantitation
of global CBF can be seen in Fig. 2B.We also did regional analyses on
cortex, hippocampus, and hypothalamus. Similar to global CBF, we
found preserved CBF in old CR rats in cortex (Fig. 2C), hippocampus
(Fig. 2D), and hypothalamus (Fig. 2E). The results indicate that CBF
reduces with age, but CR is able to impede the decline.Fig. 1. Caloric restriction reduced cerebral metabolic rate of glucose (CMRGlc) (A) CMRG
(C) Quantitative cortical CMRGlc (cCMRGlc); (D) Quantitative hippocampal CMRGlc (hCMRG
Data are presented as mean  standard error of mean. *p < 0.05; **p < 0.01; ***p < 0.001.3.3. CR reduced lactate level and increased utilization of ketone
bodies
Using HPLC-ESI-MSmethods, we observed signiﬁcantly reduced
glucose 1-phosphate/D-fructose 6-phosphate (Fig. 3A; p< 0.01) and
lactate concentrations (Fig. 3B; p < 0.01) in cortex and hippocam-
pus of the old CR rats compared with the age-matched controls.
Glucose 1-phosphate is an intermediate metabolite between the
glucose-glycogen recycling pathway and D-fructose 6-phosphate is
an intermediate in the glycolytic pathway (from glucose to pyru-
vate); lactate is the end product of glycolysis. These results were
consistent with our CMRGlc imaging ﬁndings that glucose utiliza-
tion is lower in the old CR rats.
As ketone bodies are the alternative fuel substrate in the brain
when glucose utilization goes down (Akram, 2013), we examined
concentration of ketone bodies, BHB. We found that BHB was
signiﬁcantly elevated in the CR group (Fig. 3C; 45% increase;
p< 0.01). Similar ﬁndings were found in blood ketone bodies’ level,
though the changes were not as high as in the brain (Fig. 3D; 25%
increase; p < 0.05).
3.4. CR preserved mitochondrial metabolites
We further looked into metabolites related to TCA cycle in the
cortex and hippocampus. We found that the level of citrate in the
old CR animals was signiﬁcantly higher (p< 0.01; Fig. 3E) compared
with old control animals but was not signiﬁcantly different
compared with young controls. We also found signiﬁcantly higher
a-ketoglutarate (a-KG) in the old CR group relative to the old con-
trols (p < 0.001; Fig. 3F), but indistinguishable from the young
controls.
4. Discussion
In this study, we demonstrated that CR increases the level of ke-
tone bodies and preserves CBF in aging F344BNF1 rats. We alsolc of representative control and CR rats; (B) Quantitative global CMRGlc (gCMRGlc);
lc); (E) Quantitative hypothalamic CMRGlc (htCMRGlc). N ¼ 6 per experimental group.
Abbreviations: CR, caloric restriction; SUV, standardized uptake value.
Fig. 2. Caloric restriction preserved cerebral blood ﬂow (CBF). (A) CBF maps of representative control and CR rats obtained by ASL; (B) quantitative global CBF (gCBF); (C) quantitative
cortical CBF (cCBF); (D) quantitative hippocampal CBF (hCBF); and (E) quantitative hypothalamic CBF (htCBF). N ¼ 6 per experimental group. Data are presented as mean  standard
error of the mean.**p < 0.01. Abbreviation: CR, caloric restriction.
A.-L. Lin et al. / Neurobiology of Aging 36 (2015) 2296e2303 2299observed that CR reduces glycolysis in the brain, including decreased
glucose uptake, glucose 1-phosphate/D-fructose 6-phosphate level,
and lactate concentration. Theseare consistentwithpreviousﬁndings
that CR reduces the numbers of glucose transporter (e.g., GLUT1) and
monocarboxylate transporter (e.g., MCT1) in aged rats (Roy et al.,
2013). Despite the decrease in CMRGlc, we previously showed that
themitochondrial TCA cycle ﬂux is preserved in CR old rats (Lin et al.,
2014). This couldbedue to compensatory increases in themetabolism
of ketone bodies (Hasselbalch et al., 1996; Roy et al., 2013). Preserved
metabolic and vascular functions were observed both globally and
regionally including in the cortex, hippocampus, and hypothalamus.
Because the cortex and hippocampus are highly associated
with cognitive functions (e.g., memory, learning, and perceptual
attention), our ﬁndings are in good agreement with literature that
CR slowed cognitive decline in aging F344BNF1 rats (Markowska and
Savonenko, 2002). Similar ﬁndings were also reported in humans
(Witte et al., 2009). Because the hypothalamus has glucose-sensing
neurons, reduced CMRGlc could increase the electrical activity of hy-
pothalamus orexin neurons (which are inhibited by glucose), but
suppress the excitability ofmelanin-concentrating hormoneneurons.
The consequent increased release of orexin and decreased release of
melanin-concentrating hormone stimulate wakefulness and
activity (Burdakov et al., 2005). In linewith this, CR-treated aging rats
had higher physical activity than the age-matched controls
(Carter et al., 2009). Collectively, this suggests that CR can preserve
brain physiological, cognitive, and physical function in aging.
Basedonourobservations fromthecurrent and theprevious study
(Lin et al., 2014), we summarize the pathways in Fig. 4: CR reduces
CMRGlc, but enhances ketone bodies, both globally and regionally.
Ketone bodies may come from blood stream (generated by liver) and
the fatty acid oxidation in astrocytes (Guzman and Blazquez, 2001;
Maalouf et al., 2009). We found that ketone bodies were much
higher in the brain than in the blood in the oldCR rats, suggesting that
astrocytes, not blood, contributed to increased ketone bodies. Ketone
bodies are then converted to acetoacetate, further metabolized to
acetyl-CoA, and enter into the mitochondrial TCA cycle in neurons,thus preserving mitochondrial bioenergetics (Lanza et al., 2012; Lin
et al., 2014; Lopez-Lluch et al., 2006; Maalouf et al., 2009). As a
result,we foundpreservedcitrateanda-KG levels inducedbyCR.a-KG
is transaminated to form Glu and rapidly exchange with Glu (Hertz,
2013). Glu-Gln neurotransmitter cycle communicates between neu-
rons and astrocytes to sustain neuronal activity, including maintain-
ing theneurotransmitter trafﬁckingandelicitingblood-ﬂowresponse
to energy substrate delivery (e.g., oxygen, glucose, and ketone bodies)
(Kida et al., 2001). Our ﬁnding is consistent with the preserved
Glu-Gln neurotransmission seen in CR-treated aging rats (Lin et al.,
2014). Because neuronal transmission and levels of ketone bodies
are highly associatedwith CBF (Fox and Raichle,1986; Fox et al.,1988;
Hasselbalch et al., 1996; Lin et al., 2010; Linde et al., 2006) and we
observed preserved CBF, we suggest that CR can preserve brain
metabolism, neuronal activity, and CBF and thus slow cognitive
decline in aging.
The shift from glucose metabolism to ketone bodies’ utilization
under CR is consistent with ﬁndings that ketone bodies are an alter-
native fuel for brain cells when glucose availability is insufﬁcient;
ketosis proportionally spares glucose utilization in the brain (Zhang
et al., 2013). Ketone bodies can support most, if not all, of basal
(housekeeping) neuronal oxidative metabolism. In a recent study,
Chowdhury et al. reported that acetyl-CoA oxidation from ketone
bodies accounted for approximately 62% of neuronal TCA cycle ﬂux,
while the remaining 38% was contributed by glucose, in awake rats
under hyperketonemia (Chowdhury et al., 2014). Because both brain
glucose utilization and neuronal activity decline during aging, the
shifted metabolism from glucose to ketone bodies under CR may be
able to sustain brain energy supply and functions in aging brain.
The shifted metabolism may also play an important role in pre-
servingmemory in aging since glucose plays a critical role in forming
and enhancing memory (Dash et al., 2006). As mentioned above,
glucose consumption declines with age and in an accelerated
manner in AD. Without additional or alternative fuel substrates, it is
not surprising that the ability for memory processing goes
down with age and more signiﬁcantly in AD. Emerging evidence
Fig. 3. Caloric restriction reduced glycolysis, elevated ketone bodymetabolism, and preserved brain mitochondrial tricarboxylic acid (TCA) cycle metabolites. (A) Glucose 1-phosphate/D-
fructose 6-phosphate, intermediates in the glycolytic metabolic pathway; (B) lactate, the end product of glycolysis; (C) brain ketone bodies, b-hydroxybutyrate (BHB); (D) blood ketone
bodies; (E) citrate; and (F) a-ketoglutarate, 2 intermediates in the mitochondrial TCA cycle. N ¼ 6 per experimental group. Data are presented as mean  standard error of the mean.
*p < 0.05; **p < 0.01; ***p < 0.001. Abbreviations: AUD, area under the curve; CR, caloric restriction.
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extracellular glucose levels are not sufﬁcient to maintain optimal
cognitive functions (Suzuki et al., 2011). During intense cognitive
functions, for example, astrocytic glycogenolysis is activated toprovide lactate, which is transported to neurons, converted to py-
ruvate, and enters the TCA cycle (Brown et al., 2004; Pellerin and
Magistretti, 1994). Using intrahippocampal infusion of lactate,
Newman et al. recently showed that rats had enhanced spatial
Fig. 4. Proposed metabolic and hemodynamic changes induced by caloric restriction (CR). This ﬁgure shows the comparison between old control and CR rats. CR downregulated
glucose metabolic pathway (with reduced glucose uptake, glycolysis, lactate, and glucose-glycogen recycling) but upregulated ketogenic pathway. The ketone bodies may come from
astrocytic fatty acid oxidation or blood stream. Ketone bodies are converted to acetoacetate and then further metabolized to acetyl-CoA. The altered metabolic pathway resulted in
enhanced TCA cycle ﬂux and glutamate-glutamine recycling (Vcyc(tot)) between neurons and astrocytes. Elevated CBF may be due to enhanced neuronal activity and increased ketone
bodies levels. *This was shown in our previous study (Lin et al., 2014). Abbreviations: BHB, b-hydroxybutyrate; CBF, cerebral blood ﬂow; TCA, tricarboxylic acid.
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that both brain glucose and lactate levels were lower in the CR rats,
and the brain used ketone bodies as an alternative fuel substrate
instead. Similar to lactate, ketone is generated via astrocytes
(through fatty acid oxidation pathway), indicating that astrocytes
play an important role in supplying energy substrates to neurons
when glucose level is insufﬁcient. Moreover, since the glucose level
has been chronically lower in the brain, CR rats may have not relied
on glucose as the main energy source and thus been protected from
the age-related glucose metabolism impairment (including reduced
glucose uptake, increased glucose intolerance, and increased insulin
resistance). The preserved memory functions found in aged CR rats
may be associated with the shifted metabolism from glucose to ke-
tone bodies.
In addition to sustaining neuronal activity and memory, meta-
bolism of ketone bodies has neuroprotective effects and therapeutic
potential in a variety of different common and rare disease states
(Akram, 2013; Veech, 2004). The most well known is the treatment
efﬁcacy for refractory epilepsy (Kinsman et al., 1992). Epilepsy is
caused by hyper-synchronous ﬁring of neurons. Ketone bodies are
able to maintain neurotransmission balance in epilepsy by either
increasing inhibitory neurotransmitters (e.g., g-aminobutyric acid) or
inhibiting vascular glutamate transporters (McNally and
Hartman, 2012). Others have shown that a ketogenic diet has thera-
peutic effects on diseases of insulin resistance (Veech, 2013), diseases
resulting from free radical damage, and hypoxia (Maalouf et al., 2007;
Sullivan et al., 2004). In line with this, ketogenic diets have demon-
strated improved structural and functional outcome in traumatic
brain injury models, mild traumatic brain injury/concussion models,
and spinal cord injury in preclinical studies employing both pre- andpost-injury implementation (Prins and Matsumoto, 2014). In animal
models with neurodegenerative disorders, increased ketone bodies
metabolism (by administrating a ketone ester diet) exhibit anxiolytic
and cognition-sparing properties, and lessen beta-amyloid and tau
pathologies in mouse modeling human AD (Kashiwaya et al., 2013).
This is consistent with the literature in that CR can reduce beta-
amyloid and tau deposition, and restore memory in animals
modeling human AD (Mouton et al., 2009).
Increased ketonebodiesmayalso contribute to increasedCBF. Two
studies show that an acute increase in the concentration of ketone
bodies by infusion of BHB increased the CBF without affecting the
overall cerebralmetabolic activity, suggesting thatketonebodieshave
directeffectonthecerebralendotheliumto increaseCBF, independent
of metabolic interactions (Hasselbalch et al., 1996; Linde et al., 2006).
Mammalian target of rapamycin (mTOR) signalingmay be involved in
the process. Ketogenesis is associated with downregulated mTOR
activity (Sengupta et al., 2010) and upregulated adenosine mono-
phoshateeactivated protein kinase (Blazquez et al., 1999). Both of
these changes can activate endothelial nitric oxide synthase signaling
and consequently increase CBF (Shaﬁque et al., 2013). This is consis-
tent with our previous ﬁndings thatmTOR inhibitionwith rapamycin
activates endothelial nitric oxide synthase and restores vascular
functions (CBF and vascular density) in mice modeling human AD
(Linetal., 2013;Richardsonetal., 2014). This isalsoconsistentwith the
literature in that CR preserves vascular functions and vascular density
in aging (Lynch et al., 1999; Ungvari et al., 2010).
Preserved levels of a-KG may also contribute to sustained brain
viability. As mentioned above, a-KG involves regulating Glu-Gln
neurotransmission cycling. In addition, a recent study showed that
a-KG may mimic CR and play a key role in extending life span.
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Caenorhabditis elegans had increased endogenous a-KG levels on
starvation (Chinetal., 2014). Theyalso found that thebeneﬁcial effects
of a-KG depend on the target of rapamycin inactivation. Collectively,
they suggested that a-KG is a key metabolite that mediates longevity
by dietary restriction.
The goal of this study was to identify the chronic CR effects in
normal aging brain physiology. In the future, it will be important to
investigate the acute effects on young animals and to identify the
age-dependent CR effects on brain functions as well as the correla-
tion between the brain metabolism and peripheral energy meta-
bolism. One limitation of our study is that we used a long-lived
rodentmodel to investigateCReffects.Recent studieshaveshownthat
the life spanresponse to a single level ofCR (e.g., 40%CR) varieswidely
inmicewith different genetic backgrounds (Liao et al., 2010). In some
cases, CR shortened the life span in inbredmice. Themain ﬁndings in
the studies were that CR life extension correlated inversely with fat
reductionestrains with the least reduction in fat were more likely to
show life extension, and thosewith the greatest reductionweremore
likely to have shortened life span (Liao et al., 2011). As fatty acids in
astrocytes areneeded forketonebodymetabolism, thosewith shorter
life spansmaynot beable to upregulate ketone bodyutilization under
CR. Reduction in CMRGlc without elevated ketone bodies may lead to
shorter life span. Brain metabolic and vascular functions were not
examined in these studies. Therefore, itwill be important in the future
to determine if CR also has adverse effects on brain functions during
aging in rodent strains where deleterious effects on life span are
observed.
Investigations of CR effects on brain functions are translatable.
Previous studies show that CR can improve memory in humans
(Witteet al., 2009).Because thePETandMRI imagingused inthestudy
are readily used in humans, itwould be important in future studies to
identify CR-induced changes in metabolic and vascular functions in
human brain aging using these multimetric imaging methods (Lin et
al., 2012a; 2014; Uh et al., 2011).
In conclusion, we found that CR protects brain physiology in
aging F344BNF1 rats. Upregulating ketone bodies metabolism,
sustaining CBF and a-KG (all which involve in TOR pathway) may
play a crucial role in preserving neuronal health span under CR.
These results provide a rationale for CR-induced sustenance of brain
health with extended life span. Understanding nutritional effects
on brain function may have profound implications in human aging
and other age-related neurodegenerative disorders.
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